Cargando…

A robust genomic signature for the detection of colorectal cancer patients with microsatellite instability phenotype and high mutation frequency#

Microsatellite instability (MSI) occurs in 10–20% of colorectal tumours and is associated with good prognosis. Here we describe the development and validation of a genomic signature that identifies colorectal cancer patients with MSI caused by DNA mismatch repair deficiency with high accuracy. Micro...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Sun, Roepman, Paul, Popovici, Vlad, Michaut, Magali, Majewski, Ian, Salazar, Ramon, Santos, Cristina, Rosenberg, Robert, Nitsche, Ulrich, Mesker, Wilma E, Bruin, Sjoerd, Tejpar, Sabine, Delorenzi, Mauro, Bernards, Rene, Simon, Iris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3532622/
https://www.ncbi.nlm.nih.gov/pubmed/22926706
http://dx.doi.org/10.1002/path.4092
_version_ 1782254328884494336
author Tian, Sun
Roepman, Paul
Popovici, Vlad
Michaut, Magali
Majewski, Ian
Salazar, Ramon
Santos, Cristina
Rosenberg, Robert
Nitsche, Ulrich
Mesker, Wilma E
Bruin, Sjoerd
Tejpar, Sabine
Delorenzi, Mauro
Bernards, Rene
Simon, Iris
author_facet Tian, Sun
Roepman, Paul
Popovici, Vlad
Michaut, Magali
Majewski, Ian
Salazar, Ramon
Santos, Cristina
Rosenberg, Robert
Nitsche, Ulrich
Mesker, Wilma E
Bruin, Sjoerd
Tejpar, Sabine
Delorenzi, Mauro
Bernards, Rene
Simon, Iris
author_sort Tian, Sun
collection PubMed
description Microsatellite instability (MSI) occurs in 10–20% of colorectal tumours and is associated with good prognosis. Here we describe the development and validation of a genomic signature that identifies colorectal cancer patients with MSI caused by DNA mismatch repair deficiency with high accuracy. Microsatellite status for 276 stage II and III colorectal tumours has been determined. Full-genome expression data was used to identify genes that correlate with MSI status. A subset of these samples (n = 73) had sequencing data for 615 genes available. An MSI gene signature of 64 genes was developed and validated in two independent validation sets: the first consisting of frozen samples from 132 stage II patients; and the second consisting of FFPE samples from the PETACC-3 trial (n = 625). The 64-gene MSI signature identified MSI patients in the first validation set with a sensitivity of 90.3% and an overall accuracy of 84.8%, with an AUC of 0.942 (95% CI, 0.888–0.975). In the second validation, the signature also showed excellent performance, with a sensitivity 94.3% and an overall accuracy of 90.6%, with an AUC of 0.965 (95% CI, 0.943–0.988). Besides correct identification of MSI patients, the gene signature identified a group of MSI-like patients that were MSS by standard assessment but MSI by signature assessment. The MSI-signature could be linked to a deficient MMR phenotype, as both MSI and MSI-like patients showed a high mutation frequency (8.2% and 6.4% of 615 genes assayed, respectively) as compared to patients classified as MSS (1.6% mutation frequency). The MSI signature showed prognostic power in stage II patients (n = 215) with a hazard ratio of 0.252 (p = 0.0145). Patients with an MSI-like phenotype had also an improved survival when compared to MSS patients. The MSI signature was translated to a diagnostic microarray and technically and clinically validated in FFPE and frozen samples. Copyright © 2012 Pathological Society of Great Britain and Ireland.
format Online
Article
Text
id pubmed-3532622
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher John Wiley & Sons, Ltd
record_format MEDLINE/PubMed
spelling pubmed-35326222013-01-09 A robust genomic signature for the detection of colorectal cancer patients with microsatellite instability phenotype and high mutation frequency# Tian, Sun Roepman, Paul Popovici, Vlad Michaut, Magali Majewski, Ian Salazar, Ramon Santos, Cristina Rosenberg, Robert Nitsche, Ulrich Mesker, Wilma E Bruin, Sjoerd Tejpar, Sabine Delorenzi, Mauro Bernards, Rene Simon, Iris J Pathol Original Papers Microsatellite instability (MSI) occurs in 10–20% of colorectal tumours and is associated with good prognosis. Here we describe the development and validation of a genomic signature that identifies colorectal cancer patients with MSI caused by DNA mismatch repair deficiency with high accuracy. Microsatellite status for 276 stage II and III colorectal tumours has been determined. Full-genome expression data was used to identify genes that correlate with MSI status. A subset of these samples (n = 73) had sequencing data for 615 genes available. An MSI gene signature of 64 genes was developed and validated in two independent validation sets: the first consisting of frozen samples from 132 stage II patients; and the second consisting of FFPE samples from the PETACC-3 trial (n = 625). The 64-gene MSI signature identified MSI patients in the first validation set with a sensitivity of 90.3% and an overall accuracy of 84.8%, with an AUC of 0.942 (95% CI, 0.888–0.975). In the second validation, the signature also showed excellent performance, with a sensitivity 94.3% and an overall accuracy of 90.6%, with an AUC of 0.965 (95% CI, 0.943–0.988). Besides correct identification of MSI patients, the gene signature identified a group of MSI-like patients that were MSS by standard assessment but MSI by signature assessment. The MSI-signature could be linked to a deficient MMR phenotype, as both MSI and MSI-like patients showed a high mutation frequency (8.2% and 6.4% of 615 genes assayed, respectively) as compared to patients classified as MSS (1.6% mutation frequency). The MSI signature showed prognostic power in stage II patients (n = 215) with a hazard ratio of 0.252 (p = 0.0145). Patients with an MSI-like phenotype had also an improved survival when compared to MSS patients. The MSI signature was translated to a diagnostic microarray and technically and clinically validated in FFPE and frozen samples. Copyright © 2012 Pathological Society of Great Britain and Ireland. John Wiley & Sons, Ltd 2012-12 2012-10-12 /pmc/articles/PMC3532622/ /pubmed/22926706 http://dx.doi.org/10.1002/path.4092 Text en Copyright © 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. http://creativecommons.org/licenses/by/2.5/ Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.
spellingShingle Original Papers
Tian, Sun
Roepman, Paul
Popovici, Vlad
Michaut, Magali
Majewski, Ian
Salazar, Ramon
Santos, Cristina
Rosenberg, Robert
Nitsche, Ulrich
Mesker, Wilma E
Bruin, Sjoerd
Tejpar, Sabine
Delorenzi, Mauro
Bernards, Rene
Simon, Iris
A robust genomic signature for the detection of colorectal cancer patients with microsatellite instability phenotype and high mutation frequency#
title A robust genomic signature for the detection of colorectal cancer patients with microsatellite instability phenotype and high mutation frequency#
title_full A robust genomic signature for the detection of colorectal cancer patients with microsatellite instability phenotype and high mutation frequency#
title_fullStr A robust genomic signature for the detection of colorectal cancer patients with microsatellite instability phenotype and high mutation frequency#
title_full_unstemmed A robust genomic signature for the detection of colorectal cancer patients with microsatellite instability phenotype and high mutation frequency#
title_short A robust genomic signature for the detection of colorectal cancer patients with microsatellite instability phenotype and high mutation frequency#
title_sort robust genomic signature for the detection of colorectal cancer patients with microsatellite instability phenotype and high mutation frequency#
topic Original Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3532622/
https://www.ncbi.nlm.nih.gov/pubmed/22926706
http://dx.doi.org/10.1002/path.4092
work_keys_str_mv AT tiansun arobustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency
AT roepmanpaul arobustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency
AT popovicivlad arobustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency
AT michautmagali arobustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency
AT majewskiian arobustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency
AT salazarramon arobustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency
AT santoscristina arobustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency
AT rosenbergrobert arobustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency
AT nitscheulrich arobustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency
AT meskerwilmae arobustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency
AT bruinsjoerd arobustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency
AT tejparsabine arobustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency
AT delorenzimauro arobustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency
AT bernardsrene arobustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency
AT simoniris arobustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency
AT tiansun robustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency
AT roepmanpaul robustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency
AT popovicivlad robustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency
AT michautmagali robustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency
AT majewskiian robustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency
AT salazarramon robustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency
AT santoscristina robustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency
AT rosenbergrobert robustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency
AT nitscheulrich robustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency
AT meskerwilmae robustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency
AT bruinsjoerd robustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency
AT tejparsabine robustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency
AT delorenzimauro robustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency
AT bernardsrene robustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency
AT simoniris robustgenomicsignatureforthedetectionofcolorectalcancerpatientswithmicrosatelliteinstabilityphenotypeandhighmutationfrequency